Medibiofarma

Medibiofarma is a biotechnology company that discovers and develops new chemical entities (NCEs) for the treatment of complex or untreated diseases. The company focuses on medicinal chemistry and drug design to create small molecules targeting cancer, neurodegeneration, and fibrotic Crohn’s disease. Their internal operations cover in vitro pharmacology and clinical trials, while partnering with external organizations for toxicology and IND-enabling studies.